Save time and cost with plexWell. Contact us today!

Low-pass whole-genome sequencing is an effective technical alternative to microarray-based genotyping.

The economics of using sequencing in place of microarrays is further increased by plexWell’s ability to create balanced pools of libraries that efficiently multiplex as many genomic samples as possible on high-output sequencing runs. seqWell has demonstrated the use of plexWell™ for routine low-pass human WGS applications, where we show robust and scalable genotype imputation accuracy in combination with Gencove’s imputation SaaS.

Gencove’s imputation SaaS in combination with seqWell’s low pass library preparation kit outperforms genotyping arrays.

Looking for more information?

For more information about our plexWell™ Low-pass 384 kit, please contact us to work with one of our product specialists.

Conserving California: Applying Whole Genome Sequencing in the California Conservation Genomics Project (CCGP)UPCOMING WEBINAR

Date:  May 11, 2022
Time: 12:00pm (PDT),  3:00pm (EDT), 9:00pm (CEDT)

Learning Objectives

  • Discover how the California Conservation Genomics Project is using seqWell technology to process 1000s of samples from a variety of taxa
  • Applying Whole Genome Sequencing data to conservation moving forward, particularly as it pertains to non-model species
  • Learn about the CCGP mission and goal to provide genomic data and analyses to enable better conservation efforts in California


Daniel Rodrigues Oliveira, M.S.
M.S. in Biology, CCGP Mini-Core Technician (UCLA)

Courtney Miller, Ph.D.
Integrative Biology, Fund/Project Manager CCGP (UCLA)

Ariele Hanek, Ph.D.
Director of Applications and Support, seqWell, Inc.

Caught in the Act: Tracking the Emergence and Divergence of SARS-CoV-2 through Statewide Testing and SequencingUPCOMING WEBINAR

Date:  March 23, 2022
Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEDT)

Learning Objectives

  • Understand the utility of full-genome viral sequence analysis for public health
  • Recognize how viral load impacts the ability to detect and sequence intact SARS-CoV-2
  • Identify the similarities and differences in host responses to SARS-CoV-2 depending on strain and immunologic history


Frank A. Middleton, Ph.D.
Professor Director, SUNY Molecular Analysis CoreState University of New York (SUNY) Upstate Medical University

Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer of seqWell Inc.